Abstract
Based on techniques for measuring fluorescence decay times, fluorescence lifetime imaging was developed for scanning laser microscopy (FLIM). This technique was transferred to scanning laser ophthalmoscopy to investigate the metabolic state of the healthy and diseased retina by observation of fundus autofluorescence lifetimes.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Berezin MY, Achilefu S. Fluorescence lifetime measurements and biological imaging. Chem Rev. 2010;110(5):2641–84.
Gottling PF. Determination of the time between excitation and emissionfor certain fluorescent solids. Phys Rev. 1923;22:566–73.
Gaviola E. The dacay-time of dye stuff fluorescence. Ann Phys. 1926;81:681.
Leskovar B, et al. Photon-counting system for subnanosecond fluorescence lifetime measurements. Rev Sci Instrum. 1976;47(9):1113–21.
Lewis C, et al. Measurement of short-lived fluorescence decay using single photon-counting method. Rev Sci Instrum. 1973;44(2):107–14.
Denk W, Strickler JH, Webb WW. Two-photon laser scanning fluorescence microscopy. Science. 1990;248(4951):73–6.
Skala MC, et al. In vivo multiphoton microscopy of NADH and FAD redox states, fluorescence lifetimes, and cellular morphology in precancerous epithelia. Proc Natl Acad Sci U S A. 2007;104(49):19494–9.
Walsh AJ, et al. Optical metabolic imaging identifies glycolytic levels, subtypes, and early-treatment response in breast cancer. Cancer Res. 2013;73(20):6164–74.
Walsh AJ, et al. Quantitative optical imaging of primary tumor organoid metabolism predicts drug response in breast cancer. Cancer Res. 2014;74(18):5184–94.
Walsh AJ, et al. Temporal binning of time-correlated single photon counting data improves exponential decay fits and imaging speed. Biomed Opt Express. 2016;7(4):1385–99.
Winkler K, et al. Ultrafast dynamics in the excited state of green fluorescent protein (wt) studied by frequency-resolved femtosecond pump-probe spectroscopy. Phys Chem Chem Phys. 2002;4(6):1072–81.
Chen Y, Periasamy A. Characterization of two-photon excitation fluorescence lifetime imaging microscopy for protein localization. Microsc Res Tech. 2004;63(1):72–80.
Becker W, et al. Fluorescence lifetime imaging by time-correlated single-photon counting. Microsc Res Tech. 2004;63(1):58–66.
Duncan RR, et al. Multi-dimensional time-correlated single photon counting (TCSPC) fluorescence lifetime imaging microscopy (FLIM) to detect FRET in cells. J Microsc. 2004;215:1–12.
Hell SW, Wichmann J. Breaking the diffraction resolution limit by stimulated-emission – stimulated-emission-depletion fluorescence microscopy. Opt Lett. 1994;19(11):780–2.
Auksorius E, et al. Stimulated emission depletion microscopy with a supercontinuum source and fluorescence lifetime imaging. Opt Lett. 2008;33(2):113–5.
Buckers J, et al. Simultaneous multi-lifetime multi-color STED imaging for colocalization analyses. Opt Express. 2011;19(4):3130–43.
Delori FC. Spectrometer for noninvasive measurement of intrinsic fluorescence and reflectance of ocular fundus. Appl Opt. 1994;33(31):7439–52.
von Rückmann A, Fitzke FW, Bird AC. Distribution of fundus autofluorescence with a scanning laser ophthalmoscope. Br J Ophthalmol. 1995;79:407–12.
von Rückmann A, Fitzke FW, Bird AC. Clinical application of in vivo imaging of fundus autofluorescence. Investig Ophthalmol. 1995;36(4):238.
von Rückmann A, Fitzke FW, Bird AC. In vivo fundus autofluorescence in macular dystrophies. Arch Ophthalmol. 1997;115(5):609–15.
von Rückmann A, Fitzke FW, Bird AC. Fundus autofluorescence in age-related macular disease imaged with a laser scanning ophthalmoscope. Invest Ophthalmol Vis Sci. 1997;38(2):478–86.
von Rückmann A, Fitzke FW, Bird AC. Distribution of pigment epithelium autofluorescence in retinal disease state recorded in vivo and its change over time. Graefes Arch Clin Exp Ophthalmol. 1999;237(1):1–9.
von Rückmann A, et al. Abnormalities of fundus autofluorescence in central serous retinopathy. Am J Ophthalmol. 2002;133(6):780–6.
Schmitz-Valckenberg S, et al. Analysis of digital scanning laser ophthalmoscopy fundus autofluorescence images of geographic atrophy in advanced age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol. 2002;240(2):73–8.
Schmitz-Valckenberg S, et al. Fundus autofluorescence and fundus perimetry in the junctional zone of geographic atrophy in patients with age-related macular degeneration. Invest Ophthalmol Vis Sci. 2004;45(12):4470–6.
Schmitz-Valckenberg S, et al. Correlation between the area of increased autofluorescence surrounding geographic atrophy and disease progression in patients with AMD. Invest Ophthalmol Vis Sci. 2006;47(6):2648–54.
Schmitz-Valckenberg S, et al. Optical coherence tomography and autofluorescence findings in areas with geographic atrophy due to age-related macular degeneration. Invest Ophthalmol Vis Sci. 2011;52(1):1–6.
Schmitz-Valckenberg S, et al. Semiautomated image processing method for identification and quantification of geographic atrophy in age-related macular degeneration. Invest Ophthalmol Vis Sci. 2011;52(10):7640–6.
Bindewald A, et al. Classification of fundus autofluorescence patterns in early age-related macular disease. Invest Ophthalmol Vis Sci. 2005;46(9):3309–14.
Bindewald A, et al. Classification of abnormal fundus autofluorescence patterns in the junctional zone of geographic atrophy in patients with age related macular degeneration. Br J Ophthalmol. 2005;89(7):874–8.
Einbock W, et al. Changes in fundus autofluorescence in patients with age-related maculopathy. Correlation to visual function: a prospective study. Graefes Arch Clin Exp Ophthalmol. 2005;243(4):300–5.
Schweitzer D, et al. Tau-mapping of the autofluorescence of the human ocular fundus. Proc SPIE. 2000;4164:79–89.
Schweitzer D, Kolb A, Hammer M. Autofluorescence lifetime measurements in images of the human ocular fundus. Proc SPIE. 2001;4432:29–39.
Schweitzer D, et al. Basic investigations for 2-dimensional time-resolved fluorescence measurements at the fundus. Int Ophthalmol. 2001;23:399–404.
Schweitzer D, et al. Zeitaufgelöste Messung der Autofluoreszenz – ein Werkzeug zur Erfassung von Stoffwechselvorgängen am Augenhintergrund. Opthalmologe. 2002;99(10):774–9.
Schweitzer D, et al. Evaluation of time-resolved autofluorescence images of the ocular fundus. In: Diagnostic optical spectroscopy in biomedicine II. 24–25 June 2003, Munich, Germany. 2003.
Schweitzer D, et al. In vivo measurement of time-resolved autofluorescence at the human fundus. J Biomed Opt. 2004;9(6):1214–22.
Schweitzer D, et al. Towards metabolic mapping of the human retina. Microsc Res Tech. 2007;70(5):410–9.
Schweitzer D, et al. Interpretation of measurements of dynamic fluorescence of the eye. Boston: SPIE; 2007.
Hammer M, et al. In-vivo and in-vitro investigations of retinal fluorophores in age – related macular degeneration by fluorescence lifetime imaging. In: SPIE Photonics West. 2009, SPIE.
Dysli C, et al. Quantitative analysis of fluorescence lifetime measurements of the macula using the fluorescence lifetime imaging ophthalmoscope in healthy subjects. Invest Ophthalmol Vis Sci. 2014;55(4):2106–13.
Dysli C, et al. Fluorescence lifetimes of drusen in age-related macular degeneration. Invest Ophthalmol Vis Sci. 2017;58(11):4856–62.
Dysli C, Wolf S, Zinkernagel MS. Autofluorescence lifetimes in geographic atrophy in patients with age-related macular degeneration. Invest Ophthalmol Vis Sci. 2016;57(6):2479–87.
Sauer L, et al. Monitoring foveal sparing in geographic atrophy with fluorescence lifetime imaging ophthalmoscopy – a novel approach. Acta Ophthalmol. 2018;96(3):257–66.
Sauer L, et al. Patterns of fundus autofluorescence lifetimes in eyes of individuals with nonexudative age-related macular degeneration. Invest Ophthalmol Vis Sci. 2018;59(4):AMD65–77.
Schmidt J, et al. Fundus autofluorescence lifetimes are increased in non-proliferative diabetic retinopathy. Acta Ophthalmol. 2017;95(1):33–40.
Schweitzer D, et al. Fluorescence lifetime imaging ophthalmoscopy in type 2 diabetic patients who have no signs of diabetic retinopathy. J Biomed Opt. 2015;20(6):61106.
Sauer L, et al. Fluorescence lifetime imaging ophthalmoscopy: a novel way to assess macular telangiectasia type 2. Ophthalmol Retina. 2018;2(6):587–98.
Sauer L, et al. Monitoring macular pigment changes in macular holes using fluorescence lifetime imaging ophthalmoscopy. Acta Ophthalmol. 2017;95(5):481–92.
Sauer L, et al. Fluorescence lifetime imaging ophthalmoscopy (FLIO) of macular pigment. Invest Ophthalmol Vis Sci. 2018;59(7):3094–103.
Ramm L, et al. Fluorescence lifetime imaging ophthalmoscopy in glaucoma. Graefes Arch Clin Exp Ophthalmol. 2014;252(12):2025–6.
Solberg Y, et al. Retinal flecks in Stargardt Disease reveal characteristic fluorescence lifetime transition over time. Retina. 2019;39(5):1. https://doi.org/10.1097/IAE.0000000000002519.
Dysli C, et al. Fluorescence lifetime imaging in Stargardt disease: potential marker for disease progression. Invest Ophthalmol Vis Sci. 2016;57(3):832–41.
Dysli C, Wolf S, Zinkernagel MS. Fluorescence lifetime imaging in retinal artery occlusion. Invest Ophthalmol Vis Sci. 2015;56(5):3329–36.
Dysli C, et al. Fundus autofluorescence lifetimes and central serous chorioretinopathy. Retina. 2017;37(11):2151–61.
Dysli C, et al. Autofluorescence lifetimes in patients with choroideremia identify photoreceptors in areas with retinal pigment epithelium atrophy. Invest Ophthalmol Vis Sci. 2016;57(15):6714–21.
Dysli C, et al. Fundus autofluorescence lifetime patterns in retinitis pigmentosa. Invest Ophthalmol Vis Sci. 2018;59(5):1769–78.
Andersen KM, et al. Characterization of retinitis pigmentosa using fluorescence lifetime imaging ophthalmoscopy (FLIO). Transl Vis Sci Technol. 2018;7(3):20.
Jentsch S, et al. Retinal fluorescence lifetime imaging ophthalmoscopy measures depend on the severity of Alzheimer’s disease. Acta Ophthalmol. 2015;93(4):e241–7.
Sauer L, et al. Impact of macular pigment on fundus autofluorescence lifetimes. Invest Ophthalmol Vis Sci. 2015;56(8):4668–79.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Hammer, M. (2019). FLIO Historical Background. In: Zinkernagel, M., Dysli, C. (eds) Fluorescence Lifetime Imaging Ophthalmoscopy. Springer, Cham. https://doi.org/10.1007/978-3-030-22878-1_3
Download citation
DOI: https://doi.org/10.1007/978-3-030-22878-1_3
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-22877-4
Online ISBN: 978-3-030-22878-1
eBook Packages: MedicineMedicine (R0)